(Q44648552)

5 December 2017

title

Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00216-8

amyotrophic lateral sclerosis

30 March 2024

main subject

magnesium

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00216-8

30 March 2024

author name string

Roger Pamphlett

1

1 reference

5 December 2017

Elizabeth Todd

2

1 reference

5 December 2017

Robert Vink

3

1 reference

5 December 2017

Robert McQuilty

4

1 reference

5 December 2017

Surindar S. Cheema

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607308

30 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607308

30 March 2024

publication date

1 December 2003

1 reference

5 December 2017

15 December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607308

full work available at URL

30 March 2024

https://api.elsevier.com/content/article/PII:S0022510X03002168?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00216-8

https://api.elsevier.com/content/article/PII:S0022510X03002168?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00216-8

Journal of the Neurological Sciences

30 March 2024

published in

1 reference

5 December 2017

volume

216

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

95-98

1 reference

5 December 2017

cites work

Motor neurone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Molecular mechanisms of calcium-dependent excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Magnesium: Nature's physiologic calcium blocker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

The effect of variable magnesium intake on potential factors influencing endurance capacity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Quantitative motor assessment in FALS mice: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Activators and inhibitors of the ion channel of the NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Regulation of intracellular free magnesium in central nervous system injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Hypermagnesemia does not increase brain intracellular magnesium in newborn swine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

A clinical trial of dextromethorphan in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900216-8

A method for the routine assessment of fore- and hindlimb grip strength of rats and mice

7 January 2021

11

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00216-8

30 March 2024

Identifiers

1 reference

5 December 2017

1 reference